Dual inhibition of HSP27 and FAO as a novel therapeutic strategy for cisplatin-resistant ovarian cancer

被引：0
|
作者：
Heiserman, James P.
Minhas, Zenab
Cheon, Dong-Joo
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1761
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1761
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B
    El-Senduny, Fardous F.
    Badria, Farid A.
    EL-Waseef, Ahmed M.
    Chauhan, Subhash C.
    Halaweish, Fathi
    TUMOR BIOLOGY, 2016, 37 (01) : 685 - 698
  • [22] MT-4 Suppresses Resistant Ovarian Cancer Growth through Targeting Tubulin and HSP27
    Pai, Hui Chen
    Kumar, Sunil
    Shen, Chien Chang
    Liou, Jing Ping
    Pan, Shiow Lin
    Teng, Che Ming
    PLOS ONE, 2015, 10 (04):
  • [23] The Therapeutic Effects of Dihydroartemisinin on Cisplatin-Resistant Gastric Cancer Cells
    Zhang, Suyun
    Feng, Rui
    Yuan, Fang
    Luo, Qiong
    Chen, Xiangqi
    Li, Nan
    Yang, Sheng
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2022, 23 (02) : 285 - 295
  • [24] HSP27 is Involved in Ovarian Cancer Cell Motility and Response to Paclitaxel
    Pavan, S.
    Musiani, D.
    Torchiaro, E.
    Migliardi, G.
    Olivero, M.
    Di Renzo, M. F.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S62 - S62
  • [25] Expression of the heat shock protein HSP27 in human ovarian cancer
    Langdon, SP
    Rabiasz, GJ
    Hirst, GL
    King, RJB
    Hawkins, RA
    Smyth, JF
    Miller, WR
    CLINICAL CANCER RESEARCH, 1995, 1 (12) : 1603 - 1609
  • [26] 3-Oxoacid CoA transferase 1 as a therapeutic target gene for cisplatin-resistant ovarian cancer
    Yang, San-Duk
    Ahn, So Hee
    Kim, Jong-Il
    ONCOLOGY LETTERS, 2018, 15 (02) : 2611 - 2618
  • [27] cRGD-targeted heparin nanoparticles for effective dual drug treatment of cisplatin-resistant ovarian cancer
    Liang, Xiaomei
    Yang, Yulu
    Huang, Chuanqing
    Ye, Zhibin
    Lai, Wujiang
    Luo, Jiamao
    Li, Xiaoxuan
    Yi, Xiao
    Fan, Jun-Bing
    Wang, Ying
    Wang, Yifeng
    JOURNAL OF CONTROLLED RELEASE, 2023, 356 : 691 - 701
  • [28] Ormeloxifene treatment inhibits growth of cisplatin-resistant ovarian cancer cells
    Nordquist, Jordan
    Maher, Diane M.
    Ebeling, Mara
    Jaggi, Meena
    Chauhan, Subhash C.
    CANCER RESEARCH, 2011, 71
  • [29] Silibinin-Loaded Nanostructured Lipid Carriers for Growth Inhibition of Cisplatin-Resistant Ovarian Cancer Cells
    Jafari, Sevda
    Bakhshaei, Atabak
    Eskandani, Morteza
    Molavi, Ommoleila
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2022, 20 (08) : 339 - 348
  • [30] THE ISOLATION AND CHARACTERIZATION OF CISPLATIN-RESISTANT RAT OVARIAN-CANCER CELLS
    SEKIYA, S
    OOSAKI, T
    ANDOH, S
    SUZUKI, N
    NAGAO, K
    TAKAMIZAWA, H
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (05): : 851 - +
12345